Amici A, Lagana ` A (2014) The liposomeprotein corona in mice and humans and its
implications for in vivo delivery. J Mater
Chem B 2:7419–7428
100. Pozzi D, Caracciolo G, Digiacomo L,
Colapicchioni V, Palchetti S, Capriotti AL,
Cavaliere C, Zenezini Chiozzi R, Puglisi A,
Lagana ` A (2015) The biomolecular corona of
nanoparticles in circulating biological media.
Nanoscale 7:13958–13966
101. Scho ¨ttler S, Klein K, Landfester K, Mail€ ander
V (2016) Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake. Nanoscale
8:5526–5536
102. Mahmoudi M, Abdelmonem AM, Behzadi S,
Clement JH, Dutz S, Ejtehadi MR,
Hartmann R, Kantner K, Linne U, Maffre P,
Metzler S, Moghadam MK, Pfeiffer C,
Rezaei M, Ruiz-Lozano P, Serpooshan V,
Shokrgozar MA, Nienhaus GU, Parak WJ
(2013) Temperature: the “ignored” factor at
the NanoBio interface. ACS Nano
7:6555–6562
103. Dell’Orco D, Lundqvist M, Linse S, Cedervall T (2014) Mathematical modeling of the
protein corona: implications for nanoparticulate
delivery
systems.
Nanomedicine
9:851–858
104. Smith RA, Andrews KS, Brooks D, Fedewa
SA, Manassaram-Baptiste D, Saslow D, Brawley OW, Wender RC (2018) Cancer screening
in the United States, 2018: a review of current
American Cancer Society guidelines and current issues in cancer screening. CA Cancer J
Clin 68:297–316
105. Hajipour MJ, Laurent S, Aghaie A, Rezaee F,
Mahmoudi M (2014) Personalized protein
coronas: a “key” factor at the nanobiointerface. Biomater Sci 2:1210–1221
106. Zheng T, Pierre-Pierre N, Yan X, Huo Q,
Almodovar AJO, Valerio F, Rivera-Ramirez I,
Griffith E, Decker DD, Chen S, Zhu N
(2015) Gold nanoparticle-enabled blood test
for early stage cancer detection and risk assessment.
ACS
Appl
Mater
Interfaces
7:6819–6827
107. Corbo C, Molinaro R, Tabatabaei M, Farokhzad OC, Mahmoudi M (2017) Personalized
protein corona on nanoparticles and its clinical implications. Biomater Sci 5:378–387
108. del Pilar Chantada-Va ´zquez M, Lo ´pez AC,
Bravo SB, Va ´zquez-Este ´vez S, Acea-Nebril B,
Nu ´n ˜ez C (2019) Proteomic analysis of the
bio-corona formed on the surface of (Au,
Ag, Pt)-nanoparticles in human serum. Colloids Surf B Biointerfaces 177:141–148
109. del Pilar Chantada-Va ´zquez M, Lo ´pez AC,
Vence MG, Va ´zquez-Este ´vez S, Acea-NebrilB, Calatayud DG, Jardiel T, Bravo SB, Nu ´ n ˜ez
C (2020) Proteomic investigation on
bio-corona of Au, Ag and Fe nanoparticles
for the discovery of triple negative breast cancer serum protein biomarkers. J Proteomics
212:103581
110. Zheng J, Zhou C, Yu M, Liu J (2012) Different sized luminescent gold nanoparticles.
Nanoscale 4:4073–4083
111. Lo ´ pez-Corte ´s R, Oliveira E, Nu ´ n ˜ez C,
Lodeiro C, Pa ´ez de la Cadena M, FdezRiverola F, Lo ´pez-Ferna ´ndez H, ReboiroJato M, Glez-Pen ˜a D, Luis Capelo J, Santos
HM (2012) Fast human serum profiling
through chemical depletion coupled to goldnanoparticle-assisted protein separation.
Talanta 100:239–245
112. Bastu ´ s NG, Merkoc ¸i F, Piella J, Puntes V
(2014) Synthesis of highly monodisperse
citrate-stabilized silver nanoparticles of up to
200 nm: kinetic control and catalytic properties. Chem Mater 26:2836–2846
113. Wu GW, He SB, Peng HP, Deng HH, Liu
AL, Lin XH, Xia XH, Chen W (2014) Citratecapped platinum nanoparticle as a smart
probe for ultrasensitive mercury sensing.
Anal Chem 86:10955–10960
114. Lu AH, Salabas EL, Schu ¨th F (2007) Magnetic nanoparticles: synthesis, protection,
functionalization, and application. Angew
Chem Int Ed 46:1222–1244
115. Hermida-Nogueira L, Barrachina MN,
Izquierdo I, Garcı ´a-Vence M, Lacerenza S,
Bravo S, Castrillo A, Garcı ´a A ´ (2020) Proteomic analysis of extracellular vesicles derived
from platelet concentrates treated with Mirasol
® identifies biomarkers of platelet storage
lesion. J Proteomics 210:103529
116. Bonzon-Kulichenko E, Pe ´rez-Herna ´ndez D,
Nu ´n ˜ez E, Martı ´nez-Acedo P, Navarro P,
Trevisan-Herraz M, Ramos MDC, Sierra S,
Martı ´nez-Martı ´nez S, Ruiz-Meana M, Miro ´ -Casas E, Garcı ´a-Dorado D, Redondo JM,
Burgos JS, Va ´zquez J (2011) A robust
method for quantitative high-throughput
analysis of proteomes by 18O labeling. Mol
Cell Proteomics 10:M110.003335
117. Perez-Hernandez D, Gutie ´rrez-Va ´zquez C,
Jorge I, Lo ´pez-Martı ´n S, Ursa A, Sa ´nchezMadrid F, Va ´zquez J, Ya ´n ˜ez-Mo ´ M (2013)
The intracellular interactome of tetraspaninenriched microdomains reveals their function
as sorting machineries toward exosomes. J
Biol Chem 288:11649–11661
140
Maria del Pilar Chantada-Va ´ zquez et al.
implications for in vivo delivery. J Mater
Chem B 2:7419–7428
100. Pozzi D, Caracciolo G, Digiacomo L,
Colapicchioni V, Palchetti S, Capriotti AL,
Cavaliere C, Zenezini Chiozzi R, Puglisi A,
Lagana ` A (2015) The biomolecular corona of
nanoparticles in circulating biological media.
Nanoscale 7:13958–13966
101. Scho ¨ttler S, Klein K, Landfester K, Mail€ ander
V (2016) Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake. Nanoscale
8:5526–5536
102. Mahmoudi M, Abdelmonem AM, Behzadi S,
Clement JH, Dutz S, Ejtehadi MR,
Hartmann R, Kantner K, Linne U, Maffre P,
Metzler S, Moghadam MK, Pfeiffer C,
Rezaei M, Ruiz-Lozano P, Serpooshan V,
Shokrgozar MA, Nienhaus GU, Parak WJ
(2013) Temperature: the “ignored” factor at
the NanoBio interface. ACS Nano
7:6555–6562
103. Dell’Orco D, Lundqvist M, Linse S, Cedervall T (2014) Mathematical modeling of the
protein corona: implications for nanoparticulate
delivery
systems.
Nanomedicine
9:851–858
104. Smith RA, Andrews KS, Brooks D, Fedewa
SA, Manassaram-Baptiste D, Saslow D, Brawley OW, Wender RC (2018) Cancer screening
in the United States, 2018: a review of current
American Cancer Society guidelines and current issues in cancer screening. CA Cancer J
Clin 68:297–316
105. Hajipour MJ, Laurent S, Aghaie A, Rezaee F,
Mahmoudi M (2014) Personalized protein
coronas: a “key” factor at the nanobiointerface. Biomater Sci 2:1210–1221
106. Zheng T, Pierre-Pierre N, Yan X, Huo Q,
Almodovar AJO, Valerio F, Rivera-Ramirez I,
Griffith E, Decker DD, Chen S, Zhu N
(2015) Gold nanoparticle-enabled blood test
for early stage cancer detection and risk assessment.
ACS
Appl
Mater
Interfaces
7:6819–6827
107. Corbo C, Molinaro R, Tabatabaei M, Farokhzad OC, Mahmoudi M (2017) Personalized
protein corona on nanoparticles and its clinical implications. Biomater Sci 5:378–387
108. del Pilar Chantada-Va ´zquez M, Lo ´pez AC,
Bravo SB, Va ´zquez-Este ´vez S, Acea-Nebril B,
Nu ´n ˜ez C (2019) Proteomic analysis of the
bio-corona formed on the surface of (Au,
Ag, Pt)-nanoparticles in human serum. Colloids Surf B Biointerfaces 177:141–148
109. del Pilar Chantada-Va ´zquez M, Lo ´pez AC,
Vence MG, Va ´zquez-Este ´vez S, Acea-NebrilB, Calatayud DG, Jardiel T, Bravo SB, Nu ´ n ˜ez
C (2020) Proteomic investigation on
bio-corona of Au, Ag and Fe nanoparticles
for the discovery of triple negative breast cancer serum protein biomarkers. J Proteomics
212:103581
110. Zheng J, Zhou C, Yu M, Liu J (2012) Different sized luminescent gold nanoparticles.
Nanoscale 4:4073–4083
111. Lo ´ pez-Corte ´s R, Oliveira E, Nu ´ n ˜ez C,
Lodeiro C, Pa ´ez de la Cadena M, FdezRiverola F, Lo ´pez-Ferna ´ndez H, ReboiroJato M, Glez-Pen ˜a D, Luis Capelo J, Santos
HM (2012) Fast human serum profiling
through chemical depletion coupled to goldnanoparticle-assisted protein separation.
Talanta 100:239–245
112. Bastu ´ s NG, Merkoc ¸i F, Piella J, Puntes V
(2014) Synthesis of highly monodisperse
citrate-stabilized silver nanoparticles of up to
200 nm: kinetic control and catalytic properties. Chem Mater 26:2836–2846
113. Wu GW, He SB, Peng HP, Deng HH, Liu
AL, Lin XH, Xia XH, Chen W (2014) Citratecapped platinum nanoparticle as a smart
probe for ultrasensitive mercury sensing.
Anal Chem 86:10955–10960
114. Lu AH, Salabas EL, Schu ¨th F (2007) Magnetic nanoparticles: synthesis, protection,
functionalization, and application. Angew
Chem Int Ed 46:1222–1244
115. Hermida-Nogueira L, Barrachina MN,
Izquierdo I, Garcı ´a-Vence M, Lacerenza S,
Bravo S, Castrillo A, Garcı ´a A ´ (2020) Proteomic analysis of extracellular vesicles derived
from platelet concentrates treated with Mirasol
® identifies biomarkers of platelet storage
lesion. J Proteomics 210:103529
116. Bonzon-Kulichenko E, Pe ´rez-Herna ´ndez D,
Nu ´n ˜ez E, Martı ´nez-Acedo P, Navarro P,
Trevisan-Herraz M, Ramos MDC, Sierra S,
Martı ´nez-Martı ´nez S, Ruiz-Meana M, Miro ´ -Casas E, Garcı ´a-Dorado D, Redondo JM,
Burgos JS, Va ´zquez J (2011) A robust
method for quantitative high-throughput
analysis of proteomes by 18O labeling. Mol
Cell Proteomics 10:M110.003335
117. Perez-Hernandez D, Gutie ´rrez-Va ´zquez C,
Jorge I, Lo ´pez-Martı ´n S, Ursa A, Sa ´nchezMadrid F, Va ´zquez J, Ya ´n ˜ez-Mo ´ M (2013)
The intracellular interactome of tetraspaninenriched microdomains reveals their function
as sorting machineries toward exosomes. J
Biol Chem 288:11649–11661
140
Maria del Pilar Chantada-Va ´ zquez et al.